Publicaciones en colaboración con investigadores/as de Hacettepe University (13)

2026

  1. Effect of long-term sepiapterin treatment on dietary phenylalanine tolerance in patients with phenylketonuria: Interim results from the phase 3 APHENITY Extension Study

    Genetics in Medicine, Vol. 28, Núm. 4

2025

  1. Development and implementation of the International AIDA Network Castleman’s disease registry

    Frontiers in Medicine, Vol. 12

  2. Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network

    Frontiers in Pharmacology, Vol. 16

  3. European guidelines on diagnosis and treatment of phenylketonuria: First revision

    Molecular Genetics and Metabolism, Vol. 145, Núm. 2

  4. Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry

    Frontiers in Medicine, Vol. 12

2024

  1. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table

    Journal of Clinical Lipidology, Vol. 18, Núm. 5, pp. e685-e700

  2. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

    Journal of Cystic Fibrosis, Vol. 23, Núm. 5, pp. 815-822

  3. Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)

    International Journal of Gynecological Pathology, Vol. 43, Núm. 5, pp. 436-446

2021

  1. Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

    Atherosclerosis

2020

  1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

    European Heart Journal, Vol. 41, Núm. 1, pp. 111-188

  2. Current perspectives on the use of statins in the treatment of dyslipidaemic patients: Focus on pitavastatin

    Drugs in Context

2018

  1. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

    European Heart Journal, Vol. 39, Núm. 14, pp. 1131-1143

  2. New prospects for PCSK9 inhibition?

    European heart journal